neurological manifestations of hiv infection: a practical ...neurological manifestations of hiv...

Post on 17-Mar-2020

9 Views

Category:

Documents

0 Downloads

Preview:

Click to see full reader

TRANSCRIPT

!"#"$%&%#'()* (+)&&)#(#%,-).)$/+".(0/1%"1%1(/#(23456378

69/#0-"(:"';<-)*%11)-=(:%,-).)$>("#0(:%,-)1+/%#+%

7/-%+')-=(7/9/1/)#()* (:%,-)/&&,#).)$>("#0(:%,-).)$/+".(3#*%+'/)#1

!"#$%&'"()*$%&+$*,-.%*/0123/*4".-

Intern

ation

al Neu

roinfe

ctiou

s Dise

ase C

onfer

ence

Addis

Ababa

, Ethi

opia,

on Feb

ruary

27-28

, 201

0

Intern

ation

al Neu

roinfe

ctiou

s Dise

ase C

onfer

ence

Addis

Ababa

, Ethi

opia,

on Feb

ruary

27-28

, 201

0

HIV clades worldwide

Intern

ation

al Neu

roinfe

ctiou

s Dise

ase C

onfer

ence

Addis

Ababa

, Ethi

opia,

on Feb

ruary

27-28

, 201

0

Neurological Manifestations of HIV infectionDirectly due to HIV

Sensory neuropathyVacuolar myelopathyDementia

Unmask autoimmune diseasespolymyositismyasthenia gravisAcute inflammatory demyelinating neuropathy (GBS)Multiple sclerosis

Opportunistic infectionsComplications of ART

Immune reconstitution syndrome

Intern

ation

al Neu

roinfe

ctiou

s Dise

ase C

onfer

ence

Addis

Ababa

, Ethi

opia,

on Feb

ruary

27-28

, 201

0

?)+".5(."'%-"./@/#$(1/$#1

ABB)-',#/1'/+(/#*%+'/)#1

C:8(.>&B;)&"Intern

ation

al Neu

roinfe

ctiou

s Dise

ase C

onfer

ence

Addis

Ababa

, Ethi

opia,

on Feb

ruary

27-28

, 201

0

:)#D*)+".(1/$#1E

C)$#/'/9%(0%+./#%=(-%'-)B,.1/)#=(./&F(-/$/0/'>(

"#0(;>B%--%*.%G/"

!%#/#$/'/1()-

234(0%&%#'/"Int

ernati

onal

Neuroi

nfecti

ous D

iseas

e Con

feren

ce

Addis

Ababa

, Ethi

opia,

on Feb

ruary

27-28

, 201

0

7/**%-%#'/"'/)#()* (%#+%B;".)B"';>(/#(6378

HIV Dementia CMV encephalitis

PML

Clinical Features

Psycho-motor slowing

Delirium, seizures, brainstem signs

Focal signs

Course months Days-weeks Weeks-months

CD4 count <500 <100 <100

MRI Diffuse atrophy/WM hyperintensities

periventriculitis Subcortical WM lesions

CSF Non-specific PCR+90% PCR+80%Intern

ation

al Neu

roinfe

ctiou

s Dise

ase C

onfer

ence

Addis

Ababa

, Ethi

opia,

on Feb

ruary

27-28

, 201

0

8,F+)-'/+".(H;/'%(&"''%-(.%1/)#1I(:)(

%#;"#+%&%#'(H/';(+)#'-"1'

7%%B(H;/'%(&"''%-(

;>B%-/#'%#1/'/%1I(:)(%#;"#+%&%#'(H/';(+)#'-"1'

7%%B(H;/'%(&"''%-(

;>B%-/#'%#1/'>I(:)(

%#;"#+%&%#'(H/';(+)#'-"1'

<%-/9%#'-/+,."-(.%1/)#1

Intern

ation

al Neu

roinfe

ctiou

s Dise

ase C

onfer

ence

Addis

Ababa

, Ethi

opia,

on Feb

ruary

27-28

, 201

0

<-)$-%11/)#()*(234(0%&%#'/"E(+./#/+".(*%"',-%1

J(&)#';1(&%"#(B-)$-%11/)#(,#'-%"'%01%9%-%("B"';>("#0(B1>+;)&)')-(

1.)H/#$&%&)->(.)11=(B))-(/#1/$;'$"/'(K(&)')-(/&B"/-&%#'1=('-%&)-=(

;>B%-D-%*.%G/"=(;>B%-')#/""11)+/"'%0(1>#0-)&%1E

&>%.)B"';>1%#1)->(#%,-)B"';>Int

ernati

onal

Neuroi

nfecti

ous D

iseas

e Con

feren

ce

Addis

Ababa

, Ethi

opia,

on Feb

ruary

27-28

, 201

0

:%,-).)$/+".(8/$#1(,1%*,.(/#(7/"$#)1/1()* (234D0%&%#'/"

Slow rapid eye movements, Slow limb movementsPostural instabilityHyperreflexia Hypertonia Frontal release signs

Intern

ation

al Neu

roinfe

ctiou

s Dise

ase C

onfer

ence

Addis

Ababa

, Ethi

opia,

on Feb

ruary

27-28

, 201

0

!)0/*/%0(234(0%&%#'/"(1+".%E

-)F,1'(1+-%%#/#$(')).=F,'(#)'(1B%+/*/+

1%#1/'/9/'>(L(MNO1B%+/*/+/'>(L(MPO

Intern

ation

al Neu

roinfe

ctiou

s Dise

ase C

onfer

ence

Addis

Ababa

, Ethi

opia,

on Feb

ruary

27-28

, 201

0

C8?

:)-&".()-(1./$;'(/#+-%"1%(/#(+%..1()-(B-)'%/#

Intern

ation

al Neu

roinfe

ctiou

s Dise

ase C

onfer

ence

Addis

Ababa

, Ethi

opia,

on Feb

ruary

27-28

, 201

0

MRI scan (Age:15ys)PET scan

Intern

ation

al Neu

roinfe

ctiou

s Dise

ase C

onfer

ence

Addis

Ababa

, Ethi

opia,

on Feb

ruary

27-28

, 201

0

HIV associated Neurocognitive Disorders (HAND)

Asymptomatic

Mild

Dementia

Intern

ation

al Neu

roinfe

ctiou

s Dise

ase C

onfer

ence

Addis

Ababa

, Ethi

opia,

on Feb

ruary

27-28

, 201

0

0

Time

Reversible

Chronic Inactive

Chronic Active

Subacute

High HIV RNA, no HAART or high level resistance

Low-mod HIV RNA, on HAART:Low level resistance/poor adherence

Low HIV RNA, on HAARTNo resistance/good adherence

C),-1%()* (26:7(/#(';%(Q-"()* (266RS

C),-'%1>T(U,1'/#(!+6-';,-

Intern

ation

al Neu

roinfe

ctiou

s Dise

ase C

onfer

ence

Addis

Ababa

, Ethi

opia,

on Feb

ruary

27-28

, 201

0

Prevalence of HAND in aviremicpatients (Simioni et al. 2009)

Intern

ation

al Neu

roinfe

ctiou

s Dise

ase C

onfer

ence

Addis

Ababa

, Ethi

opia,

on Feb

ruary

27-28

, 201

0

C8?(9/-".(.)"0(+)--%."'%1(H/';(1%9%-/'>()* (7%&%#'/"(V<-%D266RS(%-"W

C),-'%1>T(U,1'/#(!+6-';,-

Intern

ation

al Neu

roinfe

ctiou

s Dise

ase C

onfer

ence

Addis

Ababa

, Ethi

opia,

on Feb

ruary

27-28

, 201

0

Cumulative Incidence of HIV-DementiaDANA vs. NEAD cohorts

8"+X')-(:I((U(:%,-)9/-).I(YNNY

76:6(PZZ[DME(C7[(\YNN

:Q67(PZZM(D E(C7[(\YNN

Intern

ation

al Neu

roinfe

ctiou

s Dise

ase C

onfer

ence

Addis

Ababa

, Ethi

opia,

on Feb

ruary

27-28

, 201

0

R/1X(?"+')-1(*)-(234("11)+/"'%0(:%,-)+)$#/'/9%(7/1)-0%-1(V26:7W

Unsuppressed plasma or CSF HIV RNA

CD4 <200

Extremes of age

History of drug abuse

Anemia

Low body weight

Genetic factorsApoE4MCP-1, CCR-2TNF receptor polymorphisms

Intern

ation

al Neu

roinfe

ctiou

s Dise

ase C

onfer

ence

Addis

Ababa

, Ethi

opia,

on Feb

ruary

27-28

, 201

0

AnxietyDepressionAlcoholRecreational drugsMedication side effectsMetabolic encephalopathyHypothyroidismVitamin B12 deficiency

Drug interactions with protease inhibitors

7/**%-%#'/".(7/"$#)1/1()* (26:7

Intern

ation

al Neu

roinfe

ctiou

s Dise

ase C

onfer

ence

Addis

Ababa

, Ethi

opia,

on Feb

ruary

27-28

, 201

0

Pathology of HAND

Intern

ation

al Neu

roinfe

ctiou

s Dise

ase C

onfer

ence

Addis

Ababa

, Ethi

opia,

on Feb

ruary

27-28

, 201

0

R"#X/(%'(".I=(PZZ]

^"'%#'(3#*%+'/)#(/#("1'-)+>'%1

Productive Infection in

perivascular macrophages

Jones et al., 2000; Kruman et al., 1998

Tat

gp120

Intern

ation

al Neu

roinfe

ctiou

s Dise

ase C

onfer

ence

Addis

Ababa

, Ethi

opia,

on Feb

ruary

27-28

, 201

0

Dentate Gyrus

normal HIV no encephalitis

HIVE HIVE + drug abuse

Jones, Bell and Nath (unpublished)

Intern

ation

al Neu

roinfe

ctiou

s Dise

ase C

onfer

ence

Addis

Ababa

, Ethi

opia,

on Feb

ruary

27-28

, 201

0

virotoxinsCellular toxins

chemokines

M

Astro

Intern

ation

al Neu

roinfe

ctiou

s Dise

ase C

onfer

ence

Addis

Ababa

, Ethi

opia,

on Feb

ruary

27-28

, 201

0

Principles of Therapy for HIV CNS infection

Maximize antiretrovirals to suppress CSF HIV RNA

Preferably use CNS-

Construct simplified regime - BD or QD

Supervised therapy:Int

ernati

onal

Neuroi

nfecti

ous D

iseas

e Con

feren

ce

Addis

Ababa

, Ethi

opia,

on Feb

ruary

27-28

, 201

0

C8?(B%#%'-"'/#$(6RS1(7%*/#/'/)#E(CSF level exceeds the level needed to inhibit replication of HIV

:RS3

stavudine (D4T) zidovudine (ZDV)abacavir (ABV)

NNRTIefavirenz (EFV) nevirapine (NVP)

Protease Inhibitorsindinavir (IDV)

Intern

ation

al Neu

roinfe

ctiou

s Dise

ase C

onfer

ence

Addis

Ababa

, Ethi

opia,

on Feb

ruary

27-28

, 201

0

<-)F.%&1(H/';(+,--%#'(6RS

Poor penetration across BBBP-glycoproteinorganic transporters

Drug resistanceNo effect post viral integration

viral reservoirs sparedearly viral proteins still producedInt

ernati

onal

Neuroi

nfecti

ous D

iseas

e Con

feren

ce

Addis

Ababa

, Ethi

opia,

on Feb

ruary

27-28

, 201

0

8>&B')&"'/+(S;%-"B>

:%,-).%B'/+1E(Atypical antipsychotics6#'/0%B-%11"#'1E(Low dose fluoxetine (Prozac)6#'/+)#9,.1"#'1E 9".B-)"'%=(levitarecetam, gabapentin or topiramate. 2%"0"+;%1E Triptans interact with Protease inhibitors<"-X/#1)#/1&E poor response to dopamine agonists8.%%B(0/1',-F"#+%E Sleep apnea-protease inhibitors; Insomnia-efaverinz

Intern

ation

al Neu

roinfe

ctiou

s Dise

ase C

onfer

ence

Addis

Ababa

, Ethi

opia,

on Feb

ruary

27-28

, 201

0

Intern

ation

al Neu

roinfe

ctiou

s Dise

ase C

onfer

ence

Addis

Ababa

, Ethi

opia,

on Feb

ruary

27-28

, 201

0

HIV infection andCerebellar degeneration

(Tagliati et al., Neurology 1998;50:244-51)

Intern

ation

al Neu

roinfe

ctiou

s Dise

ase C

onfer

ence

Addis

Ababa

, Ethi

opia,

on Feb

ruary

27-28

, 201

0

HIV+ Cocaine(Meltzer et al., AJNR 1998;19:83-9)

Intern

ation

al Neu

roinfe

ctiou

s Dise

ase C

onfer

ence

Addis

Ababa

, Ethi

opia,

on Feb

ruary

27-28

, 201

0

8yr old with congenital HIV infection with microcephaly and developmental delay developed sudden onset of hemiparesis. CT showed subarachanoid hemorrhage

Intern

ation

al Neu

roinfe

ctiou

s Dise

ase C

onfer

ence

Addis

Ababa

, Ethi

opia,

on Feb

ruary

27-28

, 201

0

Intern

ation

al Neu

roinfe

ctiou

s Dise

ase C

onfer

ence

Addis

Ababa

, Ethi

opia,

on Feb

ruary

27-28

, 201

0

Riedel et al., Nature Neurol 2006

Intern

ation

al Neu

roinfe

ctiou

s Dise

ase C

onfer

ence

Addis

Ababa

, Ethi

opia,

on Feb

ruary

27-28

, 201

0

methylprednisone 1g/day x 5 days

Dramatic improvement in mental status

Discharged on prednisone 60mg/day

tenofovir, lopinavir/ritonavir, zidovudine

Intern

ation

al Neu

roinfe

ctiou

s Dise

ase C

onfer

ence

Addis

Ababa

, Ethi

opia,

on Feb

ruary

27-28

, 201

0

worseningclinical condition that is paradoxicallyattributable to the recovery of the immune system after initiation of ART

Immune Reconstitution Inflammatory Syndrome

Intern

ation

al Neu

roinfe

ctiou

s Dise

ase C

onfer

ence

Addis

Ababa

, Ethi

opia,

on Feb

ruary

27-28

, 201

0

15-25%

Patients on HAART

20-45%

Patients with OI on HAART

Shelburne et al., 2006

EPIDEMIOLOGY of IRIS

Intern

ation

al Neu

roinfe

ctiou

s Dise

ase C

onfer

ence

Addis

Ababa

, Ethi

opia,

on Feb

ruary

27-28

, 201

0

0 10 20 30 40 50 60 70 800

25

50

75

100

Patients with IRIS (%)

Tim

e in

terv

al (d

ays)

Shelburne et al., AIDS, 2005 Johnson and Nath NYAS 2010

Time between of Initiation of HAART and IRIS

Intern

ation

al Neu

roinfe

ctiou

s Dise

ase C

onfer

ence

Addis

Ababa

, Ethi

opia,

on Feb

ruary

27-28

, 201

0

Steroids:

Risks from immune suppression

Interruption of HAART/immune restorative therapy:

Risk for resistance to therapy

Re-emegence of IRIS upon restarting HAART/ immune restorative therapy

Treatment options for IRIS are not ideal

Intern

ation

al Neu

roinfe

ctiou

s Dise

ase C

onfer

ence

Addis

Ababa

, Ethi

opia,

on Feb

ruary

27-28

, 201

0

Recommendation for use of steroids in IRIS

Catastrophic IRIS: high dose steroids taper with oral steroids x 1 month (with OI prophylaxis)

Symptomatic IRIS: high dose steroids taper with oral steroids (debatable)

Asymptomatic IRIS: wait and see (debatable)

Intern

ation

al Neu

roinfe

ctiou

s Dise

ase C

onfer

ence

Addis

Ababa

, Ethi

opia,

on Feb

ruary

27-28

, 201

0

Intern

ation

al Neu

roinfe

ctiou

s Dise

ase C

onfer

ence

Addis

Ababa

, Ethi

opia,

on Feb

ruary

27-28

, 201

0

234(!>%.)B"';>

8B"1'/+/'>

8%#1)->("'"G/"

_-/#"->(1>&B')&1

Intern

ation

al Neu

roinfe

ctiou

s Dise

ase C

onfer

ence

Addis

Ababa

, Ethi

opia,

on Feb

ruary

27-28

, 201

0

Intern

ation

al Neu

roinfe

ctiou

s Dise

ase C

onfer

ence

Addis

Ababa

, Ethi

opia,

on Feb

ruary

27-28

, 201

0

Peripheral Nervous System with HIV

RadiculopathyGBSMononeuritis multiplexSensory motor neuropathy

Intern

ation

al Neu

roinfe

ctiou

s Dise

ase C

onfer

ence

Addis

Ababa

, Ethi

opia,

on Feb

ruary

27-28

, 201

0

CMV PolyradiculitisOccurs late in HIV infection; CD4 usually < 100; concurrent CMV infection in >60%Cauda equina syndrome: asymmetric motor, perineal sensory, back pain, sphincter CSF: poly pleocytosis, protein, glucose, + CMV PCR+ in 95%

Rx: Induction: ganciclovir [+ foscarnet]Maintenance: valganciclovir

Intern

ation

al Neu

roinfe

ctiou

s Dise

ase C

onfer

ence

Addis

Ababa

, Ethi

opia,

on Feb

ruary

27-28

, 201

0

C!4(B).>-"0/+,./'/1%#;"#+/#$(#%-9%(-))'1#%+-)'/+(-))'1C!4(/#+.,1/)#11B/#".(+)-0(/#9).9%&%#'

!R3(1+"#

C),-'%1>E(U,1'/#(!+6-';,-

Intern

ation

al Neu

roinfe

ctiou

s Dise

ase C

onfer

ence

Addis

Ababa

, Ethi

opia,

on Feb

ruary

27-28

, 201

0

Intern

ation

al Neu

roinfe

ctiou

s Dise

ase C

onfer

ence

Addis

Ababa

, Ethi

opia,

on Feb

ruary

27-28

, 201

0

HIV-associated GBS

Increased frequency of GBS relative to general populationSimilar presentation to HIV neg, except that CSF usually cellularUsually presents early in HIV infectionPresumably an immune-mediated phenomenon

Responds to plasmapheresis or IVIG

7%&>%./#"'%0(#%-9%(1%$&%#'1

C),-'%1>E(U,1'/#(!+6-';,-

Intern

ation

al Neu

roinfe

ctiou

s Dise

ase C

onfer

ence

Addis

Ababa

, Ethi

opia,

on Feb

ruary

27-28

, 201

0

:%-9%(F/)B1>(1;)H1(&"+-)B;"$%(&%0/"'%0(0%&>%./#"'/)#(/#(234D"11)+/"'%0(`a8

C),-'%1>E(U,1'/#(!+6-';,-

Intern

ation

al Neu

roinfe

ctiou

s Dise

ase C

onfer

ence

Addis

Ababa

, Ethi

opia,

on Feb

ruary

27-28

, 201

0

!)#)#%,-/'/1(&,.'/B.%G(/#(234(/#*%+'/)#

"F-,B'()#1%'1%9%-%(B"/#2%B"'/'/1(a(K(C-%b,/-%1(#%-9%(aGRGE(1'%-)/01

4%11%.()++.,1/)#("#0(/#*."&&"'/)#(/#(H"..

C),-'%1>E(U,1'/#(!+6-';,-

Intern

ation

al Neu

roinfe

ctiou

s Dise

ase C

onfer

ence

Addis

Ababa

, Ethi

opia,

on Feb

ruary

27-28

, 201

0

Incidence of neuropathyLichenstein CID 2004

Intern

ation

al Neu

roinfe

ctiou

s Dise

ase C

onfer

ence

Addis

Ababa

, Ethi

opia,

on Feb

ruary

27-28

, 201

0

Clinical features of HIV sensory neuropathies

Common length-dependent symptoms:Spontaneous pain in feet, paresthesias, Evoked pain ~ touch, rubbing (not cold) Numbness ~ unusual in fingersLancinating pains

Examination:sens. thresholds 85%

96%Distal weakness 33%Atrophy or wasting 30%Fasciculations 0%

Features of HIV distal sensory polyneuropathy and antiretroviral toxic neuropathy are identical. Neuropathic sx. are correlated with plasma HIV RNA

C)-#F."';=(PZccT(S"$./"'/(!=(PZZZC),-'%1>E(U,1'/#(!+6-';,-

52

Intern

ation

al Neu

roinfe

ctiou

s Dise

ase C

onfer

ence

Addis

Ababa

, Ethi

opia,

on Feb

ruary

27-28

, 201

0

Antiretroviral exposure: d4T 8-fold, ddI 4-fold

Diabetes in 11% of HAART recipients; IGT in ~ 20%

Alcohol abuse; hepatitis C

Entrapment neuropathies

Vitamin deficiencies or overuse

C)#*),#0/#$(/..#%11%1(/#(';%("11%11&%#'()* (234(1%#1)->(#%,-)B"';/%1

Intern

ation

al Neu

roinfe

ctiou

s Dise

ase C

onfer

ence

Addis

Ababa

, Ethi

opia,

on Feb

ruary

27-28

, 201

0

!"#$%&'"()*"#+,-"+,%.*"./*.)0$%."1*$)/0#+,%.*,.*234*#%$$)1"+)5*6,+'*789:;<****!"#$%&'()'*++,-

[]O(

[]OInt

ernati

onal

Neuroi

nfecti

ous D

iseas

e Con

feren

ce

Addis

Ababa

, Ethi

opia,

on Feb

ruary

27-28

, 201

0

Skin biopsy technique

!"#$"%&'(#)&*&+&&,""-'.//&012(3

4)"'3&012(3&'56"'

55

Intern

ation

al Neu

roinfe

ctiou

s Dise

ase C

onfer

ence

Addis

Ababa

, Ethi

opia,

on Feb

ruary

27-28

, 201

0

Skin biopsy assesses unmyelinated nerve fibers

Thigh: normal density Distal leg: reduced density and nerve fiber

swellings

HIV sensory neuropathies

%B/0%-&/1

56

Intern

ation

al Neu

roinfe

ctiou

s Dise

ase C

onfer

ence

Addis

Ababa

, Ethi

opia,

on Feb

ruary

27-28

, 201

0

V,#./+%#1%0W(('-%"'&%#'1(*)-(234(1%#1)->(#%,-)B"';/%1

=">%+$,(,.)?*!"#$%"&&'(410#0$%.,/"+,%.@*$"5'

A%&,$">"+)?*)(*+","+'3)."1*)B#$)+,%.@*6+*1%55@*C,/.)D*5+%.)5

4"E"&).+,.F&$)("E"1,.-#./0'(+"#$"($1*,3)."1*)B#$)+,%.@*)/)>"@*5)/"+,%.

201%B)+,.)?*5)$%+%.,.F.%$)&,.)&'$,.)*338<"05)"@*')&"+%+%B,#,+D

G%>E,."+,%.*+')$"&,)5?*)(*<HI!*5+0/D*%J*("E"&).+,.*K*>%$&',.)

Intern

ation

al Neu

roinfe

ctiou

s Dise

ase C

onfer

ence

Addis

Ababa

, Ethi

opia,

on Feb

ruary

27-28

, 201

0

6+X#)H.%0$%&%#'1

Intern

ation

al Neu

roinfe

ctiou

s Dise

ase C

onfer

ence

Addis

Ababa

, Ethi

opia,

on Feb

ruary

27-28

, 201

0

6+X#)H.%0$%&%#'1

Intern

ation

al Neu

roinfe

ctiou

s Dise

ase C

onfer

ence

Addis

Ababa

, Ethi

opia,

on Feb

ruary

27-28

, 201

0

Intern

ation

al Neu

roinfe

ctiou

s Dise

ase C

onfer

ence

Addis

Ababa

, Ethi

opia,

on Feb

ruary

27-28

, 201

0

Intern

ation

al Neu

roinfe

ctiou

s Dise

ase C

onfer

ence

Addis

Ababa

, Ethi

opia,

on Feb

ruary

27-28

, 201

0

top related